Adicet Bio, Inc. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
Adicet Bio, Inc. (ACET) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $2.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-19.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2024-03-19
- Adicet Bio, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $2.00K.
- Adicet Bio, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2021 was $0.00.
- Adicet Bio, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2018 was $69.00K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2022-12-31 | $2.00K 10-K · filed 2024-03-19 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-15 |
| 2018-12-31 | $69.00K 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |